Association between DNA Methylation in the miR-328 5′-Flanking Region and Inter-individual Differences in miR-328 and BCRP Expression in Human Placenta

被引:22
作者
Saito, Jumpei [1 ]
Hirota, Takeshi [1 ]
Furuta, Shinji [1 ]
Kobayashi, Daisuke [1 ]
Takane, Hiroshi [2 ]
Ieiri, Ichiro [1 ]
机构
[1] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmacokinet, Fukuoka 812, Japan
[2] Tottori Univ Hosp, Dept Pharm, Yonago, Tottori, Japan
基金
日本学术振兴会;
关键词
CANCER-RESISTANCE-PROTEIN; SINGLE NUCLEOTIDE POLYMORPHISMS; LIMITS FETAL DISTRIBUTION; BREAST-CANCER; PROMOTER METHYLATION; ABCG2; EXPRESSION; P-GLYCOPROTEIN; MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; TRANSPORTER;
D O I
10.1371/journal.pone.0072906
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
MicroRNA (miRNA) are non-coding small RNA that regulate gene expression. MiR-328 is reported to influence breast cancer resistance protein (BCRP) expression in cancer cells. As a large inter-individual difference in BCRP levels is observed in various human tissues, the contribution of miR-328 to these differences is of interest. We hypothesized that DNA methylation in the miR-328 promoter region is responsible for the difference in miR-328 levels, leading to inter-individual variability in BCRP levels in human placenta. The association between placental miR-328 and BCRP levels was analyzed, and then DNA methylation in the miR-328 5'-flanking region and regulatory mechanisms causing inter-individual differences in miR-328 and BCRP levels were examined. MiR-328 expression was significantly correlated with BCRP mRNA (Rs = -0.560, P < 0.01) and protein (Rs = -0.730, P < 0.01) levels. It was also up-regulated by the demethylating agent 5-aza-2'-deoxycytidine in BCRP-expressing cells. Luciferase assays with differentially methylated reporter constructs indicated that methylation in the miR-328 5'-flanking region including a predicted CpG island remarkably decreased transcriptional activity compared to that in unmethylated constructs. We selected CCAAT/enhancer binding protein alpha (C/EBP alpha), located within the predicted CpG island, by in silico analysis. To elucidate the role of C/EBPa in miR-328 expression, a chromatin immunoprecipitation assay, promoter deletion analysis, and electrophoretic mobility shift assay (EMSA) were performed. C/EBP alpha-binding site-truncated constructs showed significantly decreased promoter activity, and EMSA indicated that the C/EBP alpha-binding sites were located in the CpG island. Finally, the methylation patterns of several CpG dinucleotides proximal to two C/EBP alpha-binding sites in the miR-328 5'-flanking region were correlated negatively with miR-328 levels, and positively with BCRP levels in human placental samples. These results suggest that methylation patterns in the miR-328 5'-flanking region are involved in the inter-individual difference in BCRP levels in human placenta.
引用
收藏
页数:15
相关论文
共 65 条
[1]  
Allen JD, 2002, MOL CANCER THER, V1, P427
[2]   Increased Expression of P-Glycoprotein and Doxorubicin Chemoresistance of Metastatic Breast Cancer Is Regulated by miR-298 [J].
Bao, Lili ;
Hazari, Sidhartha ;
Mehra, Smriti ;
Kaushal, Deepak ;
Moroz, Krzysztof ;
Dash, Srikanta .
AMERICAN JOURNAL OF PATHOLOGY, 2012, 180 (06) :2490-2503
[3]   miR-192/miR-215 Influence 5-Fluorouracil Resistance through Cell Cycle-Mediated Mechanisms Complementary to Its Post-transcriptional Thymidilate Synthase Regulation [J].
Boni, Valentina ;
Bitarte, Nerea ;
Cristobal, Ion ;
Zarate, Ruth ;
Rodriguez, Javier ;
Maiello, Evaristo ;
Garcia-Foncillas, Jesus ;
Bandres, Eva .
MOLECULAR CANCER THERAPEUTICS, 2010, 9 (08) :2265-2275
[4]   Single-step doxorubicin-selected cancer cells overexpress the ABCG2 drug transporter through epigenetic changes [J].
Calcagno, A. M. ;
Fostel, J. M. ;
To, K. K. W. ;
Salcido, C. D. ;
Martin, S. E. ;
Chewning, K. J. ;
Wu, C-P ;
Varticovski, L. ;
Bates, S. E. ;
Caplen, N. J. ;
Ambudkar, S. V. .
BRITISH JOURNAL OF CANCER, 2008, 98 (09) :1515-1524
[5]   Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line bewo [J].
Ceckova, M ;
Libra, A ;
Pavek, P ;
Nachtigal, P ;
Brabec, M ;
Fuchs, R ;
Staud, F .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2006, 33 (1-2) :58-65
[6]   Frequent Downregulation of miR-34 Family in Human Ovarian Cancers [J].
Corney, David C. ;
Hwang, Chang-Il ;
Matoso, Andres ;
Vogt, Markus ;
Flesken-Nikitin, Andrea ;
Godwin, Andrew K. ;
Kamat, Aparna A. ;
Sood, Anil K. ;
Ellenson, Lora H. ;
Hermeking, Heiko ;
Nikitin, Alexander Yu. .
CLINICAL CANCER RESEARCH, 2010, 16 (04) :1119-1128
[7]   Hypermethylation of CpG Islands and Shores around Specific MicroRNAs and Mirtrons Is Associated with the Phenotype and Presence of Bladder Cancer [J].
Dudziec, Ewa ;
Miah, Saiful ;
Choudhry, Hani M. Z. ;
Owen, Helen C. ;
Blizard, Sheila ;
Glover, Maggie ;
Hamdy, Freddie C. ;
Catto, James W. F. .
CLINICAL CANCER RESEARCH, 2011, 17 (06) :1287-1296
[8]   Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) gene [J].
Ee, PLR ;
Kamalakaran, S ;
Tonetti, D ;
He, XL ;
Ross, DD ;
Beck, WT .
CANCER RESEARCH, 2004, 64 (04) :1247-1251
[9]   Effect of breast cancer resistance protein (Bcrp/Abcg2) on the disposition of phytoestrogens [J].
Enokizono, Junichi ;
Kusuhara, Hiroyuki ;
Sugiyama, Yuichi .
MOLECULAR PHARMACOLOGY, 2007, 72 (04) :967-975
[10]   The xenobiotic transporter ABCG2 plays a novel role in differentiation of trophoblast-like BeWo cells [J].
Evseenko, D. A. ;
Paxton, J. W. ;
Keelan, J. A. .
PLACENTA, 2007, 28 :S116-S120